Pacific Biosciences of California, Inc. (PACB)
2.43
+0.11
(+4.74%)
USD |
NASDAQ |
Dec 09, 16:00
2.41
-0.02
(-0.82%)
After-Hours: 20:00
Pacific Biosciences of California EPS Diluted (Quarterly): -0.1263 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bruker Corp. | -0.4111 |
| ICU Medical, Inc. | -0.1376 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Clearpoint Neuro, Inc. | -0.2072 |
| Intellia Therapeutics, Inc. | -0.9196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.00M |
| Revenue (Quarterly) | 38.44M |
| Total Expenses (Quarterly) | 76.44M |
| Enterprise Value | 1.135B |
| Gross Profit Margin (Quarterly) | 39.20% |
| Profit Margin (Quarterly) | -98.85% |
| Earnings Yield | -89.54% |
| Normalized Earnings Yield | -93.42 |